Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced positive top-line Phase II study results for its novel ...

Mark Sheppard's daughter got married a year and a half ago — and he got to walk her down the aisle. "Something I never ...

Forced oscillation technique (FOT) can enhance early detection and management of progressive pulmonary fibrosis.

Phase 1 Clinical Trials Among the Company’s Five Poster Presentations 4.5 Year Long-Term Safety and Efficacy Data Supporting ...

A little-known drug may offer hope for a currently incurable and deadly condition, with many patients dying within three ...

Qureight’s cloud-based, vendor-agnostic Core Imaging Platform is GDPR, HIPPA and NHS Digital compliant. The platform has ...

A drug that is currently used for cancer could be the key in treating a disease that has no cure, and a life expectancy of ...

Late-breaking oral presentation to highlight further evidence supporting potential for deupirfenidone to serve as a new standard of care for the treatment of idiopathic pulmonary fibrosis (IPF) ...

A cancer drug could help a condition which is incurable and fatal with many of those who have the condition dying within 3 ...

A collaboration between Nasdaq quoted biopharma company Rein Therapeutics in Texas and Cambridge UK innovator Qureight Ltd ...